A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants
Status:
Completed
Trial end date:
2020-09-14
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effect of multiple-dose administration
of lansoprazole on the single-dose pharmacokinetics (PK) of JNJ-64417184 in healthy adult
participants; and to evaluate the effect of time-separated, multiple-dose administration of
famotidine on the single-dose PK of JNJ-64417184 in healthy adult participants (optional).